R&D Projects

R&D Projects 2016-12-12T16:03:43+01:00

R&D projects implemented by the members of Lublin Cluster of Healthcare and Wellness Services

“FlexiOss” – two-phase, resilient bone-substituting biomaterial for in vivo research.
Leader Prof. Grażyna Ginalska -Biochemy and Biotechnology Unit at Medical University of Lublin and Izabela Polkowska, PhD – Department of Veterinary Medicine at University of Life Sciences in Lublin
Partners Medical University of Lublin and University of Life Sciences in Lublin
Information The project aims at identifying opportunities for applying bone-substituting compound for filling defects in laboratory animals’ bones. Taking the achieved results into consideration, it can be stated that the new-generation implanting material can be applied in dentistry, orthopaedics, and veterinary. NCN research grant no. N N308 582 440
Preliminary clinical evaluation of the new bone-substituting compound created and patented in Biochemistry and Biotechnology Department at Medical University of Lublin
Leader Prof. Grażyna Ginalska – Medical University of Lublin (Biochemistry and Biotechnology Department) and Małgorzata Kiernicka, PhD – “New Dent Dentistry Clinic”
Partners Medical University of Lublin, Medical Inventi S.A., and “New Dent Dentistry Clinic”.
Information Bioethical Commission at Medical University of Lublin authorised the “New Dent Dentistry Clinic” to conduct clinical observation of the new biomaterial provided by Medical Inventi S.A. (dentistry surgery fillings). All cases are periodically assessed in clinical environment; application of this material for the aforementioned purposes did not produce any side effects.
Developing innovative technology of producing laser microprobes applied in cancer diagnoses.
Leader SDS Optic Sp. z o.o.
Partners SDS Optic Sp z o.o., Medical University of Lublin, University of Life Sciences in Lublin, Medical University of Wrocław, Polish Center for Photonics and Fiber Optics.
Informstion R&D works will result in producing a prototype of a laser microprobe used for finding HER2 and CCL5 tumor indicators as well as for detecting medicine effect rate in treating tumours during developing tomour therapies. The innovaative technology being developed will be of international importance. SDS Optic aims to strengthen its position internationally in terms of scientific research and development works conducted in the fields covered in the project as well as to start exporting the aforementioned devices.